COVID-19 – IISA

2 December, 2024

Posted by Communication - IIS Aragón el 2 December, 2024

The 'Difficult to diagnose and treat Infections Group' of the IIS Aragón (GIIS023) recently published two of its latest investigations

The first study reflects the national work on COVID-19 epidemiological surveillance, associated with a European research project of excellence (H2020), which served as a pilot for the design of the current official national COVID-19 surveillance system. The second is a study commissioned by the ECDC on healthcare workers on surveillance and effectiveness of the COVID-19 vaccine.

November 14, 2024

Posted by Communication - IIS Aragón el November 14, 2024

New therapeutic approach for severe COVID-19: faster recovery and reduced mortality

An international study, with the participation of the University of Zaragoza and the Aragón Health Research Institute (IIS Aragón), has tested a new therapeutic strategy to treat severe COVID. It is a clinical trial whose results are published in eClinicalMedicine and which could also be applied to other respiratory viruses.

October 29, 2024

Posted by Communication - IIS Aragón el October 29, 2024

The COVID-19 pandemic in Aragon highlighted the differences in healthcare between men and women

A study by the Health Services Research Group of Aragon (GRISSA), of the University of Zaragoza and the IIS Aragón, reveals that men were hospitalized more frequently than women